Cargando…
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
Several obstacles limit the efficacy of brain tumour treatment, most notably the blood‐brain barrier (BBB), which prevents the brain uptake of the majority of accessible medicines due to tight junctions. The presence of glutathione (GSH) receptors on the BBB surface has been demonstrated in numerous...
Autores principales: | Mehrabian, Amin, Dadpour, Saba, Mashreghi, Mohammad, Zarqi, Javad, Askarizadeh, Anis, Badiee, Ali, Arabi, Leila, Moosavian, Seyedeh Alia, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116028/ https://www.ncbi.nlm.nih.gov/pubmed/36594666 http://dx.doi.org/10.1049/nbt2.12111 |
Ejemplares similares
-
Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach
por: Mehrabian, Amin, et al.
Publicado: (2022) -
The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
por: Dadpour, Saba, et al.
Publicado: (2022) -
Nanocarriers Call the Last Shot
in the Treatment of Brain Cancers
por: Mehrabian, Amin, et al.
Publicado: (2022) -
Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy
por: Mirhadi, Elaheh, et al.
Publicado: (2022) -
Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023)